ClinicalTrials.Veeva

Menu

Hypertonic Saline Resuscitation in Trauma Patients After Hemorrhage Control (CELTA)

F

Fundacion Clinica Valle del Lili

Status and phase

Terminated
Phase 4

Conditions

Abdominal Injuries

Treatments

Drug: Sodium Chloride [3%]
Drug: Sodium Chloride [0.9%]

Study type

Interventional

Funder types

Other

Identifiers

Details and patient eligibility

About

This study aimed to determine whether hypertonic saline solution is effective in the resuscitation of injured patients undergoing abdominal damage control surgery regarding early closure of the abdominal wall.

Full description

A double-blind, controlled, randomized clinical trial was conducted to determine the impact of an infusion of hypertonic saline 3% vs. isotonic saline 0.9% at a dose of 50 mL/hr for the first 72 hours in patients with abdominal trauma requiring damage control surgery regarding some clinically relevant outcomes. These outcomes were: The timing of abdominal cavity closure, fluids balance, abdominal hypertension, and abdominal compartment syndrome occurrence, organ dysfunction, and 28 days' mortality.

Enrollment

52 patients

Sex

All

Ages

16+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Abdominal trauma requiring damage control surgery.
  • Acceptance by the patient or by a proxy to be included in the trial.

Exclusion criteria

  • Concomitant severe head trauma, defined by a Glasgow score <9, before receiving sedation or by the presence of cerebral edema or intracranial injury on a CT-scan.
  • Pregnancy
  • Patient not included 4 hours or more after damage control surgery.
  • Damage control laparotomy performed for other indications other than trauma.
  • Not index damage control laparotomy
  • No acceptance to participate in the study.

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Quadruple Blind

52 participants in 2 patient groups

Sodium Chloride [3%]
Experimental group
Treatment:
Drug: Sodium Chloride [3%]
Sodium Chloride [0.9%]
Active Comparator group
Treatment:
Drug: Sodium Chloride [0.9%]

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems